Athira Pharma Inc [ATHA] stock prices are down -1.81% to $0.28 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ATHA shares have gain 5.29% over the last week, with a monthly amount drifted -5.77%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Athira Pharma Inc [NASDAQ: ATHA] stock has seen the most recent analyst activity on September 19, 2024, when Mizuho downgraded its rating to a Neutral and also revised its price target to $0.50 from $5. Previously, Rodman & Renshaw downgraded its rating to Neutral on September 04, 2024. On September 04, 2024, downgrade downgraded it’s rating to Mkt Perform. BTIG Research downgraded its rating to a Neutral. Rodman & Renshaw initiated its recommendation with a Buy and recommended $22 as its price target on August 19, 2024. JMP Securities upgraded its rating to Mkt Outperform for this stock on October 17, 2022, but kept the price target unchanged to $20. In a note dated July 07, 2022, Mizuho initiated an Buy rating and provided a target price of $6 on this stock.
The stock price of Athira Pharma Inc [ATHA] has been fluctuating between $0.22 and $3.67 over the past year. Currently, Wall Street analysts expect the stock to reach $18 within the next 12 months. Athira Pharma Inc [NASDAQ: ATHA] shares were valued at $0.28 at the most recent close of the market. An investor can expect a potential return of 6328.57% based on the average ATHA price forecast.
Analyzing the ATHA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.83, Equity is -1.43 and Total Capital is -2.18. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.2752 points at the first support level, and at 0.2676 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.2891, and for the 2nd resistance point, it is at 0.2954.
Ratios To Look Out For
It’s worth pointing out that Athira Pharma Inc [NASDAQ:ATHA]’s Current Ratio is 7.26. Further, the Quick Ratio stands at 7.26, while the Cash Ratio is 4.81.
Transactions by insiders
Recent insider trading involved San Martin Javier, CHIEF MEDICAL OFFICER, that happened on Jan 02 ’25 when 10826.0 shares were sold. President and CEO, Litton Mark James completed a deal on Jan 02 ’25 to sell 25107.0 shares. Meanwhile, CHIEF SCIENTIFIC OFFICER CHURCH KEVIN sold 8510.0 shares on Jan 02 ’25.
